Works matching IS 08876924 AND DT 2004 AND VI 18 AND IP 5

Results: 26

CD34+ progenitors from MDS patients are unresponsive to SDF-1, despite high levels of SDF-1 in bone marrow plasma.

Published in:

2004

By:

Matsuda, M.;
Morita, Y.;
Hanamoto, H.;
Tatsumi, Y.;
Maeda, Y.;
Kanamaru, A.

Publication type:

Letter

Interactive ChimerTrack software facilitates computation, visual displays and long-term tracking of chimeric status based on STRs.

Published in:

Leukemia (08876924), 2004, v. 18, n. 5, p. 909, doi. 10.1038/sj.leu.2403325

By:

Krist, D.;
Stein, J.;
Yaniv, I.;
Klein, T.

Publication type:

Article

Predictive factors for successful stem cell mobilization in patients with indolent lymphoproliferative disorders previously treated with fludarabine.

Published in:

2004

By:

Morgan, S. J.;
Seymour, J. F.;
Grigg, A.;
Matthews, J. P.;
Prince, H. M.;
Wolf, M. M.;
Januszewicz, E. H.

Publication type:

Letter

Deletion of 7p or monosomy 7 in pediatric acute lymphoblastic leukemia is an adverse prognostic factor: a report from the Children's Cancer Group.

Published in:

Leukemia (08876924), 2004, v. 18, n. 5, p. 939, doi. 10.1038/sj.leu.2403327

By:

Heerema, N. A.;
Nachman, J. B.;
Sather, H. N.;
La, M. K.;
Hutchinson, R.;
Lange, B. J.;
Bostrom, B.;
Steinherz, P. G.;
Gaynon, P. S.;
Uckun, F. M.

Publication type:

Article

CDDO induces apoptosis via the intrinsic pathway in lymphoid cells.

Published in:

2004

By:

Inoue, S.;
Snowden, R. T.;
Dyer, M. J. S.;
Cohen, G. M.

Publication type:

journal article

Immunophenotypic normalization of aberrant mast cells accompanies histological remission in imatinib-treated patients with eosinophilia-associated mastocytosis.

Published in:

2004

By:

Elliott, M. A.;
Pardanani, A.;
Li, C. Y.;
Tefferi, A.

Publication type:

Letter

Preferential expression of the vasoactive intestinal peptide (VIP) receptor VPAC1 in human cord blood-derived CD34+CD38- cells: possible role of VIP as a growth-promoting factor for hematopoietic stem/progenitor cells.

Published in:

Leukemia (08876924), 2004, v. 18, n. 5, p. 912, doi. 10.1038/sj.leu.2403330

By:

Kawakami, M.;
Kimura, T.;
Kishimoto, Y.;
Tatekawa, T.;
Baba, Y.;
Nishikazi, T.;
Matsuzaki, N.;
Taniguchi, Y.;
Yoshihara, S.;
Ikegame, K.;
Shirakata, T.;
Nishida, S.;
Masuda, T.;
Hosen, N.;
Tsuboi, A.;
Oji, Y.;
Oka, Y.;
Ogawa, H.;
Sonoda, Y.

Publication type:

Article

Bone marrow endothelial cells increase the invasiveness of human multiple myeloma cells through upregulation of MMP-9: evidence for a role of hepatocyte growth factor.

Published in:

Leukemia (08876924), 2004, v. 18, n. 5, p. 976, doi. 10.1038/sj.leu.2403331

By:

Broek, I. Vande;
Asosingh, K.;
Allegaert, V.;
Leleu, X.;
Facon, T.;
Vanderkerken, K.;
Van Camp, B.;
van Riet, I.

Publication type:

Article

Activation of the HIF pathway in childhood ALL, prognostic implications of VEGF.

Published in:

Leukemia (08876924), 2004, v. 18, n. 5, p. 926, doi. 10.1038/sj.leu.2403332

By:

Wellman, S.;
Guschmann, M.;
Griethe, W.;
Eckert, C.;
Stackelberg, Av.;
Lottaz, C.;
Moderegger, E.;
Einsiedel, H. G.;
Eckardt, K.-U.;
Henze, G.;
Seeger, K.

Publication type:

Article

IL-6 regulates CD44 cell surface expression on human myeloma cells.

Published in:

Leukemia (08876924), 2004, v. 18, n. 5, p. 967, doi. 10.1038/sj.leu.2403333

By:

Vincent, T.;
Mechti, N.

Publication type:

Article

FLJ10849, a septin family gene, fuses MLL in a novel leukemia cell line CNLBC1 derived from chronic neutrophilic leukemia in transformation with t(4;11)(q21;q23).

Published in:

2004

By:

Kojima, K.;
Sakai, I.;
Hasegawa, A.;
Niiya, H.;
Azuma, T.;
Matsuo, Y.;
Fujii, N.;
Tanimoto, M.;
Fujita, S.

Publication type:

journal article

Growth autonomy and lineage switching in BCR-ABL-transduced human cord blood cells depend on different functional domains of BCR-ABL.

Published in:

Leukemia (08876924), 2004, v. 18, n. 5, p. 1006, doi. 10.1038/sj.leu.2403335

By:

Chalandon, Y.;
Jiang, X.;
Loutet, S.;
Eaves, A. C.;
Eaves, C. J.

Publication type:

Article

Addition of cladribine to daunorubicin and cytarabine increases complete remission rate after a single course of induction treatment in acute myeloid leukemia. Multicenter, phase III study.

Published in:

Leukemia (08876924), 2004, v. 18, n. 5, p. 989, doi. 10.1038/sj.leu.2403336

By:

Holowiecki, J.;
Grosicki, S.;
Robak, T.;
Kyrcz-Krzemien, S.;
Giebel, S.;
Hellman, A.;
Skonticki, A.;
Jedrejczak, W. W.;
Konopka, L.;
Kuliczowski, K.;
Zdziarska, B.;
Dmoszynska, A.;
Marianska, B.;
Pluta, A.;
Zawilska, K.;
Komarnicki, M.;
Kloczko, J.;
Sulek, K.;
Haus, O.

Publication type:

Article

Prognostic impact of p27KIP1 expression in cyclin D1 positive lymphoproliferative disorders.

Published in:

Leukemia (08876924), 2004, v. 18, n. 5, p. 953, doi. 10.1038/sj.leu.2403337

By:

Letestu, R.;
Ugo, V.;
Valensi, F.;
Radford-Weiss, I.;
Nataf, J.;
Lévy, V.;
Gribben, J. G.;
Troussard, X.;
Ajchenbaum-Cymbalista, F.

Publication type:

Article

Secondary imatinib resistance associated with an aberrant bcr-abl fusion gene.

Published in:

2004

By:

Janssen, J. J. W. M.;
Hochhaus, A.;
van Oostveen, J. W.;
Waisfisz, Q.;
Schuurhuis, G. J.;
Ossenkoppele, G. J.

Publication type:

Letter

Improvement of gene expression analysis by RQ-PCR technology: addition of BSA.

Published in:

2004

By:

Silvy, M.;
Pic, G.;
Gabert, J.;
Picard, C.

Publication type:

Letter

Split-signal FISH for detection of chromosome aberrations in acute lymphoblastic leukemia.

Published in:

Leukemia (08876924), 2004, v. 18, n. 5, p. 895, doi. 10.1038/sj.leu.2403340

By:

Wang, L.;
Poulsen, T. S.;
Hunger, S. P.;
Beverloo, H. B.;
Smit, E. M. E.;
Vang-Nielsen, K.;
Langerak, A. W.;
van Dongen, J. J. M.

Publication type:

Article

Dendritic cells become BCR-ABL negative in chronic myeloid leukaemia patients successfully treated with imatinib.

Published in:

2004

By:

Wang, L.;
Butt, N. M.;
Atherton, M. G.;
Clark, R. E.

Publication type:

Letter

Effect of graft-versus-host disease on the outcome of bone marrow transplantation from an HLA-identical sibling donor using GVHD prophylaxis with cyclosporin A and methotrexate.

Published in:

Leukemia (08876924), 2004, v. 18, n. 5, p. 1013, doi. 10.1038/sj.leu.2403343

By:

Kanda, Y.;
Izutsu, K.;
Hirai, H.;
Sakamaki, H.;
Iseki, T.;
Kodera, Y.;
Okamoto, S.;
Mitsui, H.;
Iwato, K.;
Hirabayashi, N.;
Furukawa, T.;
Maruta, A.;
Kasai, M.;
Atsua, Y.;
Hamajima, N.;
Hiroaki, A.;
Kawa, K.

Publication type:

Article

Predicting survival for myeloid leukemia after HLA-identical sibling donor allogeneic stem cell transplantation.

Published in:

2004

By:

Gallardo, D.;
De la Cámara, R.;
Torres, A.;
Brunet, S.;
Jiménez, A.;
Vallejo, J. C.;
Sanz, G.;
Serrano, D.;
Carreras, E.;
Martin, C.;
Sanz-Rodríguez, C.;
Sierra, J.;
Espigado, I.;
Caballero, D.;
Berlanga, J. J.

Publication type:

Letter

Novel chromosomal aberrations in Philadelphia negative cells of chronic myelogenous leukemia patients on imatinib: report of three cases.

Published in:

2004

By:

Athanasiadou, A.;
Stavroyianni, N.;
Saloum, R.;
Asteriou, O.;
Anagnostopoulos, A.;
Fassas, A.

Publication type:

Letter

Targeting FGFR3 in multiple myeloma: inhibition of t(4;14)-positive cells by SU5402 and PD173074.

Published in:

Leukemia (08876924), 2004, v. 18, n. 5, p. 962, doi. 10.1038/sj.leu.2403347

By:

Grand, E. K.;
Chase, A. J.;
Heath, C.;
Rahemtulla, A.;
Cross, N. C. P.

Publication type:

Article

Expression of the adaptor protein BLNK/SLP-65 in childhood acute lymphoblastic leukemia.

Published in:

Leukemia (08876924), 2004, v. 18, n. 5, p. 922, doi. 10.1038/sj.leu.2403349

By:

Imai, C.;
Ross, M. E.;
Reid, G.;
Coustan-Smith, E.;
Schultz, K. R.;
Pui, C. H.;
Downing, J. R.;
Campana, D.

Publication type:

Article

High CD33-antigen loads in peripheral blood limit the efficacy of gemtuzumab ozogamicin (Mylotarg) treatment in acute myeloid leukemia patients.

Published in:

2004

By:

van der Velden, V. H. J.;
Boeckx, N.;
Jedema, I.;
te Marvelde, J. G.;
Hoogeveen, P. G.;
Boogaerts, M.;
van Dongen, J. J. M.

Publication type:

journal article

DNA microarrays for comparison of gene expression profiles between diagnosis and relapse in precursor-B acute lymphoblastic leukemia: choice of technique and purification influence the identification of potential diagnostic markers.

Published in:

2004

By:

Staal, F J T;
van der Burg, M;
Wessels, L F A;
Barendregt, B H;
Baert, M R M;
van den Burg, C M M;
Van Huffel, C;
Langerak, A W;
van der Velden, V H J;
Reinders, M J T;
van Dongen, J J M

Publication type:

Correction Notice

Comparative analysis of flow cytometry and polymerase chain reaction for the detection of minimal residual disease in childhood acute lymphoblastic leukemia.

Published in:

Leukemia (08876924), 2004, v. 18, n. 5, p. 934, doi. 10.1038/sj.leu.2403348

By:

Neale, G. A. M.;
Coustan-Smith, E.;
Stow, P.;
Pan, Q.;
Chen, X.;
Pui, C.-H.;
Campana, D.

Publication type:

Article

Works matching IS 08876924 AND DT 2004 AND VI 18 AND IP 5

CD34<sup>+</sup> progenitors from MDS patients are unresponsive to SDF-1, despite high levels of SDF-1 in bone marrow plasma.

Interactive ChimerTrack software facilitates computation, visual displays and long-term tracking of chimeric status based on STRs.

Predictive factors for successful stem cell mobilization in patients with indolent lymphoproliferative disorders previously treated with fludarabine.

Deletion of 7p or monosomy 7 in pediatric acute lymphoblastic leukemia is an adverse prognostic factor: a report from the Children's Cancer Group.

CDDO induces apoptosis via the intrinsic pathway in lymphoid cells.

Immunophenotypic normalization of aberrant mast cells accompanies histological remission in imatinib-treated patients with eosinophilia-associated mastocytosis.

Preferential expression of the vasoactive intestinal peptide (VIP) receptor VPAC1 in human cord blood-derived CD34<sup>+</sup>CD38<sup>-</sup> cells: possible role of VIP as a growth-promoting factor for hematopoietic stem/progenitor cells.

Bone marrow endothelial cells increase the invasiveness of human multiple myeloma cells through upregulation of MMP-9: evidence for a role of hepatocyte growth factor.

Activation of the HIF pathway in childhood ALL, prognostic implications of VEGF.

IL-6 regulates CD44 cell surface expression on human myeloma cells.

FLJ10849, a septin family gene, fuses MLL in a novel leukemia cell line CNLBC1 derived from chronic neutrophilic leukemia in transformation with t(4;11)(q21;q23).

Growth autonomy and lineage switching in BCR-ABL-transduced human cord blood cells depend on different functional domains of BCR-ABL.

Addition of cladribine to daunorubicin and cytarabine increases complete remission rate after a single course of induction treatment in acute myeloid leukemia. Multicenter, phase III study.

Prognostic impact of p27KIP1 expression in cyclin D1 positive lymphoproliferative disorders.

Secondary imatinib resistance associated with an aberrant bcr-abl fusion gene.

Improvement of gene expression analysis by RQ-PCR technology: addition of BSA.

Split-signal FISH for detection of chromosome aberrations in acute lymphoblastic leukemia.

Dendritic cells become BCR-ABL negative in chronic myeloid leukaemia patients successfully treated with imatinib.

Effect of graft-versus-host disease on the outcome of bone marrow transplantation from an HLA-identical sibling donor using GVHD prophylaxis with cyclosporin A and methotrexate.

Predicting survival for myeloid leukemia after HLA-identical sibling donor allogeneic stem cell transplantation.

Novel chromosomal aberrations in Philadelphia negative cells of chronic myelogenous leukemia patients on imatinib: report of three cases.

Targeting FGFR3 in multiple myeloma: inhibition of t(4;14)-positive cells by SU5402 and PD173074.

Expression of the adaptor protein BLNK/SLP-65 in childhood acute lymphoblastic leukemia.

High CD33-antigen loads in peripheral blood limit the efficacy of gemtuzumab ozogamicin (Mylotarg) treatment in acute myeloid leukemia patients.

DNA microarrays for comparison of gene expression profiles between diagnosis and relapse in precursor-B acute lymphoblastic leukemia: choice of technique and purification influence the identification of potential diagnostic markers.

Comparative analysis of flow cytometry and polymerase chain reaction for the detection of minimal residual disease in childhood acute lymphoblastic leukemia.